shark cartilage extract AE-941
Term · Oncology and biomedicine · MLC-T-ONC-016703
A multifunctional antiangiogenic agent derived from shark cartilage with potential antineoplastic activity. Shark cartilage extract AE-941 competitively inhibits the binding of pro-angiogenic vascular endothelial growth factor (VEGF) to its cell receptor, thereby inhibiting endothelial cell proliferation. This agent also inhibits matrix metalloproteinases (MMPs), stimulates tissue plasminogen activator (tPA), and activates caspase-mediated apoptotic pathways in endothelial cells.
| Identifier | MLC-T-ONC-016703 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Neovastat/AE-941 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016703",
"term": "shark cartilage extract AE-941",
"field": "Oncology and biomedicine",
"definition": "A multifunctional antiangiogenic agent derived from shark cartilage with potential antineoplastic activity. Shark cartilage extract AE-941 competitively inhibits the binding of pro-angiogenic vascular endothelial growth factor (VEGF) to its cell receptor, thereby inhibiting endothelial cell proliferation. This agent also inhibits matrix metalloproteinases (MMPs), stimulates tissue plasminogen activator (tPA), and activates caspase-mediated apoptotic pathways in endothelial cells.",
"synonyms": [
"Neovastat/AE-941"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/shark-cartilage-extract-ae-941/"
}
Record 14,924 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.